These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
447 related articles for article (PubMed ID: 28441157)
1. New role of mechanical assist device as bridge to transplant: USA perspective. Mohamed A; Mehta N; Eisen HJ Curr Opin Organ Transplant; 2017 Jun; 22(3):231-235. PubMed ID: 28441157 [TBL] [Abstract][Full Text] [Related]
2. Current status of mechanical circulatory support for treatment of advanced end-stage heart failure: successes, shortcomings and needs. Sunagawa G; Koprivanac M; Karimov JH; Moazami N; Fukamachi K Expert Rev Cardiovasc Ther; 2017 May; 15(5):377-387. PubMed ID: 28351172 [TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment. Health Quality Ontario Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798 [TBL] [Abstract][Full Text] [Related]
4. The Use of Left Ventricular Assist Devices in End-Stage Heart Failure. Blair A Crit Care Nurs Q; 2018; 41(4):376-382. PubMed ID: 30153180 [TBL] [Abstract][Full Text] [Related]
5. Device therapy and cardiac transplantation for end-stage heart failure. Boilson BA; Raichlin E; Park SJ; Kushwaha SS Curr Probl Cardiol; 2010 Jan; 35(1):8-64. PubMed ID: 19962044 [TBL] [Abstract][Full Text] [Related]
6. Left ventricular assist device: a bridge to transplant or destination therapy? Patel S; Nicholson L; Cassidy CJ; Wong KY Postgrad Med J; 2016 May; 92(1087):271-81. PubMed ID: 26969730 [TBL] [Abstract][Full Text] [Related]
7. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure. Long EF; Swain GW; Mangi AA Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450 [TBL] [Abstract][Full Text] [Related]
8. Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation. Chew DS; Manns B; Miller RJH; Sharma N; Exner DV Can J Cardiol; 2017 Oct; 33(10):1283-1291. PubMed ID: 28941608 [TBL] [Abstract][Full Text] [Related]
9. Device profile of the heartware HVAD system as a bridge-to-transplantation in patients with advanced heart failure: overview of its safety and efficacy. Mariani S; Hanke JS; Li T; Merzah AS; Chatterjee A; Deniz E; Haverich A; Schmitto JD; Dogan G Expert Rev Med Devices; 2019 Dec; 16(12):1003-1015. PubMed ID: 31774339 [No Abstract] [Full Text] [Related]
10. Left Ventricular Assist Device Driveline Infections: The Achilles' Heel of Destination Therapy. Angud M AACN Adv Crit Care; 2015; 26(4):300-5. PubMed ID: 26484989 [TBL] [Abstract][Full Text] [Related]
11. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure. Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601 [TBL] [Abstract][Full Text] [Related]
12. Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation. Clegg AJ; Scott DA; Loveman E; Colquitt JL; Royle P; Bryant J Eur Heart J; 2006 Dec; 27(24):2929-38. PubMed ID: 16603577 [TBL] [Abstract][Full Text] [Related]
13. Institutional Cost Comparison Between Heart Transplants and Left Ventricular Assist Device Implantations. Chimanji N; Kilic A; Hasan A; Higgins RS; Whitson BA; Kilic A Exp Clin Transplant; 2016 Dec; 14(6):656-659. PubMed ID: 27063391 [TBL] [Abstract][Full Text] [Related]
15. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables. John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659 [TBL] [Abstract][Full Text] [Related]
16. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices. Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132 [TBL] [Abstract][Full Text] [Related]
17. Post-heart transplantation outcome of HeartMate II-bridged recipients requiring unplanned concomitant temporary right ventricular mechanical support. Urban M; Pirk J; Szarszoi O; Besik J; Netuka I Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):372-8. PubMed ID: 25487235 [TBL] [Abstract][Full Text] [Related]
18. Heart failure and mechanical circulatory assist devices. La Franca E; Iacona R; Ajello L; Sansone A; Caruso M; Assennato P Glob J Health Sci; 2013 May; 5(5):11-9. PubMed ID: 23985102 [TBL] [Abstract][Full Text] [Related]
19. From left ventricular assist device to transplant to home: An interdisciplinary team approach to treating medically complex cardiac patients during the bridge to transplantation: A case report. Foster KJ; Cota A; Cleves S J Rehabil Med; 2017 Jan; 49(1):91-93. PubMed ID: 27904909 [TBL] [Abstract][Full Text] [Related]
20. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]